Study of Diaphragmatic Ultrasound as a Predictor of Mechanical Ventilation in Patients With Respiratory Diseases on Admission to Intensive Care Unit
NCT ID: NCT06254417
Last Updated: 2024-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
62 participants
INTERVENTIONAL
2024-02-01
2024-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Diaphragmatic ultrasound had been used before as a tool to predict weaning from mechanical ventilation.
In this study diaphragmatic ultrasound will be done upon admission to predict of mechanical ventilation in patients with respiratory diseases.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Diaphragmatic Ultrasound as a Predictor of Extubation From Mechanical Ventilation
NCT05063526
Diaphragmatic Thickening Fraction as a Predictor of Successful Weaning
NCT06465082
Ultrasound-Assessed Diaphragmatic Dysfunction as a Predictor of Weaning Outcome
NCT04825509
Ultrasound-Guided Diaphragmatic Thickness Assessment as an Indicator of Successful Extubation in Mechanically Ventilated
NCT03894436
Diaphragmatic Ultrasound as a Guide Tool During Weaning From Mechanical Ventilation
NCT03608332
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Complete physical examination: general and local examination will be carried out for all patients.
All cases undergo standard monitoring including invasive and non-invasive blood pressure monitoring, SpO2 and ECG.
Full laboratory investigations: At the beginning of the study (Arterial blood gases, CBC, Coagulation Profile, Kidney function tests, Liver function tests, Cardiac enzymes).
All patients will be treated according to the international guidelines according to their medical status . As well as Hemodynamic support will be provided by fluids resuscitation and/or catecholamine infusion if necessary, to keep mean arterial pressure \>70 mmHg.
Respiratory support will consist of oxygen administration or mechanical ventilation if necessary, to maintain SPO2 \> 90% and PH \> 7.25.
Diaphragmatic ultrasound will be performed to all patients with respiratory disease to evaluate diaphragmatic thickening and estimate thickening fraction and to evaluate diaphragmatic excursion. Measurements will be obtained at bedside with a portable ultrasound machine equipped with a linear probe (Logic P6 Pro, GE Healthcare). Diaphragmatic thickness measures will be performed on right Intercostal approach through the zone of apposition. Diaphragmatic excursion will be performed using curved-array probe (Logic P6 Pro, GE Healthcare) is positioned below right costal arch at the mid-clavicular line. The ultrasound study will be done and /or supervised by ultrasound expert.
The decision of using mechanical ventilation will not depend on the diaphragmatic ultrasound results.
Primary outcome: estimation of diaphragmatic thickening fraction which will predict mechanical ventilation.
Secondary outcome: estimation of diaphragmatic excursion which will predict mechanical ventilation.
Non invasive ventilation (NIV) will be delivered through a full-face mask connected to a high-performance ventilator. In non-invasive pressure support mode. PEEP and delivered FIO2 will be set to achieve oxygen saturation target of 88-92%. Pressure support level will be adjusted to obtain a target volume of 6-8 mL/kg, a frequency \< 30 breaths/min, and air leak \< 15%. Cycling will be set at 40% of peak flow. If non-invasive ventilation failed or patient deteriorated invasive ventilation will be required.
Indication of non invasive ventilation:
* Moderate to sever dyspnea increased over usual , respiratory rate more than24 cycle/ min, accessory muscle use and paradoxical breathing.
* Pao2 more than 55 mmHg.
* PH between 7.25 and 7.35.
* Pao2 /Fio2 less than 200.
* Hypoxia So2 less than 88% on O2
Indication of invasive ventilation:
* any contraindication of non invasive ventilation.
* Failure of non invasive ventilation after (1:2) hours.
* Hemodynamic instability. (Decrease base line values \>20% on admission)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NON VENTILATED GROUP
Diaphragmatic ultrasound
Diaphragmatic ultrasound will be performed to all patients with respiratory disease to evaluate diaphragmatic thickening and estimate thickening fraction and to evaluate diaphragmatic excursion. Measurements will be obtained at bedside with a portable ultrasound machine equipped with a linear probe (Logic P6 Pro, GE Healthcare). Diaphragmatic thickness measures will be performed on right Intercostal approach through the zone of apposition. Diaphragmatic excursion will be performed using curved-array probe (Logic P6 Pro, GE Healthcare) is positioned below right costal arch at the mid-clavicular line. The ultrasound study will be done and /or supervised by ultrasound expert
VENTILATED GROUP
Diaphragmatic ultrasound
Diaphragmatic ultrasound will be performed to all patients with respiratory disease to evaluate diaphragmatic thickening and estimate thickening fraction and to evaluate diaphragmatic excursion. Measurements will be obtained at bedside with a portable ultrasound machine equipped with a linear probe (Logic P6 Pro, GE Healthcare). Diaphragmatic thickness measures will be performed on right Intercostal approach through the zone of apposition. Diaphragmatic excursion will be performed using curved-array probe (Logic P6 Pro, GE Healthcare) is positioned below right costal arch at the mid-clavicular line. The ultrasound study will be done and /or supervised by ultrasound expert
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diaphragmatic ultrasound
Diaphragmatic ultrasound will be performed to all patients with respiratory disease to evaluate diaphragmatic thickening and estimate thickening fraction and to evaluate diaphragmatic excursion. Measurements will be obtained at bedside with a portable ultrasound machine equipped with a linear probe (Logic P6 Pro, GE Healthcare). Diaphragmatic thickness measures will be performed on right Intercostal approach through the zone of apposition. Diaphragmatic excursion will be performed using curved-array probe (Logic P6 Pro, GE Healthcare) is positioned below right costal arch at the mid-clavicular line. The ultrasound study will be done and /or supervised by ultrasound expert
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hypoxia: as SO2 \< 92% on room air.
* Hypercapnia: as PaCO2 \> 45mmHg.
Exclusion Criteria
* Cardiogenic pulmonary edema.
* History of interstitial lung disease (fibrosis).
* Neuromuscular disease.
* Significant chest wall deformities.
* Previous diagnosis of diaphragmatic palsy.
* Recent thoracotomy or sternotomy (within the previous year).
* Severe hemodynamic instability or shock.
* Pregnancy.
* Diagnosis of pneumothorax or pneumo mediastinum.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
RAMY AHMED
Assistant Professor of Anesthesia
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
master ICU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.